Controlling gene expression to halt cancer growth
October 25, 2011 BY LAURA GOUIN in Cancer(Medical Xpress) -- NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.
But difficult doesnt mean impossible, and Olaf Wiest, professor of chemistry and biochemistry at the University of Notre Dame, is one of a group of collaborators studying the effects of a specific molecule (JQ1) on the trigger that controls the growth of this form of cancer.
Most people are familiar with genetics and the role they play in our height, hair color, and even predisposition to various diseases. But there is this whole other world called epigenetics that controls which genes are expressed and which arent, says Wiest.
This epigenetic world is made up of three classes of proteins: writers, erasers and readers, collectively the instruction manual that tells a gene when to activate and when to cease activation. Writers will create the instruction for the gene while erasers will remove instructions. Readers control the group and issue the start and stop commands for genes to use their instructions.
The reason NMC is so aggressive is because these cancer cells divide very fast, says Wiest. This rapid-growth is caused by the protein BRD4, an epigenetic reader that interacts with another protein called a histone. Their interaction changes the instructions for the gene and keeps the growth trigger permanently activated.
The solution is that you have to block that protein, Wiest says. Which is something that is traditionally very difficult in protein-to-protein interactions because the binding between them is not very strong. Normally when youre talking to somebody in chemistry and say youre going to target a protein to protein interaction, they say youre nuts.
Of course the way to prove them wrong is to go on and do it, he concludes.
There is already a vast amount of information on writers and a lot of interest in erasers in the research community because there are two FDA approved drugs that control erasers. Research into epigenetic readers, however, is relatively new.
Wiest says it wasnt such a big step for him and his 21 colleagues to move from erasers to readers in their studies. Their recent focus has been on a small molecule called JQ1 that tricks the NUT midline carcinoma cancer cells by disrupting the protein-to-protein interaction. It not only halts the constant growth command but it also makes the cancer cells forget their instructions and begin to resemble normal cells.
Wiests research showed that the protein is less flexible in the presence of JQ1, allowing it overcome the weak bindings. Animal studies produced very encouraging results. Laboratory mice transplanted with NMC cells from patients and given JQ1 lived, those that were not given JQ1 died.
Wiests hope is that through continued studies on the effectiveness of JQ1, an effective and non-invasive therapy can be found for NMC and other aggressive cancers.
Provided by
University of Notre Dame
-
Researchers create first molecule blocks key component of cancer genes' on-off switch
Sep 24, 2010 |
not rated yet |
0
-
Scientists discover how antibiotic molecule found in bacteria stops breast cancer
Aug 22, 2011 |
not rated yet |
0
-
'Detox protein' is collaborator in pancreatic and lung cancer development
Jul 06, 2011 |
not rated yet |
0
-
Novel approach scores first success against elusive cancer gene
Sep 09, 2011 |
not rated yet |
0
-
Scientists discover potential new target for prostate cancer treatment
Feb 13, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
6 hours ago
-
Popping/Cracked sternum.
11 hours ago
-
Which Mental Illness Encompasses This Problem?
11 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
19 hours ago |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
20 hours ago |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
21 hours ago |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
23 hours ago |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
May 25, 2012 |
not rated yet |
1
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Inherited DNA change explains overactive leukemia gene
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Early physical therapist treatment associated with reduced risk of healthcare utilization and reduced overall healthcare
A new study published in Spine shows that early treatment by a physical therapist for low back pain (LBP), as compared to delayed treatment, was associated with reduced risk of subsequent healthcare utilization and lower ...